OTCM OTC Markets Group Cl A

aTyr Pharma to Present at Life Sciences Investor Forum on September 17th

aTyr Pharma to Present at Life Sciences Investor Forum on September 17th

SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (the “Company”) (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present a company overview at the Virtual Life Sciences Investor Forum, which is being held on Thursday, September 17.

Details of the event are as follows:

Date: Thursday September 17, 2020

Presentation Time: 11:30 a.m. Eastern Time

Webcast Link:



This will be a live, interactive online event where investors are invited to ask the Company questions in real-time. The presentation and Q&A session will be webcast live and can be accessed at . Investors are encouraged to pre-register to expedite participation and receive event updates. Please access the website at least 15 minutes in advance of the scheduled presentation time to register and run the online system check. 

Please visit to register and learn more about the event.

Recent Company Highlights:

A replay of the presentation will be available following the event on the Investor’s section of the Company’s website at .



About aTyr

aTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. aTyr’s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyr’s primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in inflammatory lung diseases. For more information, please visit .

About Life Sciences Investor Forum

Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors. A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

Contact:
Ashlee Dunston
Investor Relations, aTyr Pharma
 

Life Sciences Investor Forum
John M. Viglotti
SVP Corporate Services, Investor Access
(212) 220-2221
EN
02/09/2020

Underlying

OTCMOTC Markets Group Cl A

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OTC Markets Group Cl A

 PRESS RELEASE
Free
OTCM OTC Markets Gro...

OTC Markets Group Welcomes Southern Cross Gold Consolidated Ltd. to OT...

OTC Markets Group Welcomes Southern Cross Gold Consolidated Ltd. to OTCQX NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (TSX: SXGC; ASX: SX2; OTCQX: SXGCF), a company engaged in the acquisition and exploration of mineral properties in Australia, has qualified to trade on the OTCQX® Best Market. Southern Cross Gold Consolidated Ltd. upgraded to OTCQX from the Pink® market. Southern Cross Gold Consolidated Ltd. begins trading today on OTCQX under the symbol “SXGCF.” U.S. inves...

August 19, 2025 1 EN
 PRESS RELEASE
Free
OTCM OTC Markets Gro...

OTC Markets Group Welcomes MÉLIUZ S.A. to OTCQX

OTC Markets Group Welcomes MÉLIUZ S.A. to OTCQX NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (OTCQX: MLIZY), the first Bitcoin Treasury Company in Brazil and Latin America fully dedicated to accretively growing its Bitcoin holdings for shareholders while consistently delivering a positive Bitcoin Yield. While pursuing this strategic objective, the Company also operates a robust technology-driven platform that accelerates sales by generating qualified traffic for partner stor...

August 15, 2025 1 EN
 PRESS RELEASE
Free
OTCM OTC Markets Gro...

OTC Markets Group Welcomes First Phosphate Corp. to OTCQX

OTC Markets Group Welcomes First Phosphate Corp. to OTCQX NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (CSE: PHOS; OTCQX: FRSPF), an igneous phosphate mineral development company for the LFP battery industry, has qualified to trade on the OTCQX® Best Market. First Phosphate Corp. upgraded to OTCQX from the OTCQB® Venture Market. First Phosphate Corp. begins trading today on OTCQX under the symbol “FRSPF.” U.S. investors can find current financial disclosure and Real-Time ...

August 12, 2025 1 EN
 PRESS RELEASE
Free
OTCM OTC Markets Gro...

OTC Markets Group Welcomes Limitless X Holdings Inc. to OTCQX

OTC Markets Group Welcomes Limitless X Holdings Inc. to OTCQX NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (OTCQX: LIMX), a company that specializes in direct-to-consumer eCommerce, has qualified to trade on the OTCQX® Best Market. Limitless X Holdings Inc. upgraded to OTCQX from the OTCQB® Venture Market. Limitless X Holdings Inc. begins trading today on OTCQX under the symbol “LIMX.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for...

August 11, 2025 1 EN
 PRESS RELEASE
Free
OTCM OTC Markets Gro...

OTC Markets Group Reports Second Quarter 2025 Financial Results Delive...

OTC Markets Group Reports Second Quarter 2025 Financial Results Delivering Revenue, Operating Income, and Earnings Growth Second Quarter 2025 Highlights: Gross revenues of $30.5 million for the quarter, up 11% versus the prior year periodOperating income of $8.8 million for the quarter, up 8% versus the prior year periodOperating profit margin of 29.9%, versus 30.4% for the prior year periodNet income of $7.3 million, up 8% versus the prior year period, and quarterly diluted GAAP EPS of $0.60, up 7% Total cash returned to shareholders during the quarter of $2.2 million, in the form of divi...

August 6, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch